Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Filters applied: . Clear all
Page 1
Vaccines from the Spanish Influenza as a firm foundation for new developments.
Oxford JS, Gill D. Oxford JS, et al. Hum Vaccin Immunother. 2020 Aug 12:1-5. doi: 10.1080/21645515.2020.1793710. Online ahead of print. Hum Vaccin Immunother. 2020. PMID: 32783768
A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian.
Oxford JS, Gill D. Oxford JS, et al. Hum Vaccin Immunother. 2019;15(9):2009-2012. doi: 10.1080/21645515.2019.1607711. Epub 2019 May 23. Hum Vaccin Immunother. 2019. PMID: 31121112 Free PMC article.
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
Lambkin-Williams R, Gelder C, Broughton R, Mallett CP, Gilbert AS, Mann A, He D, Oxford JS, Burt D. Lambkin-Williams R, et al. Among authors: oxford js. PLoS One. 2016 Dec 22;11(12):e0163089. doi: 10.1371/journal.pone.0163089. eCollection 2016. PLoS One. 2016. PMID: 28005959 Free PMC article. Clinical Trial.
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
Mann AJ, Noulin N, Catchpole A, Stittelaar KJ, de Waal L, Veldhuis Kroeze EJ, Hinchcliffe M, Smith A, Montomoli E, Piccirella S, Osterhaus AD, Knight A, Oxford JS, Lapini G, Cox R, Lambkin-Williams R. Mann AJ, et al. Among authors: oxford js. PLoS One. 2014 May 21;9(5):e93761. doi: 10.1371/journal.pone.0093761. eCollection 2014. PLoS One. 2014. PMID: 24850536 Free PMC article.
Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination.
Moss AJ, Gaughran FP, Karasu A, Gilbert AS, Mann AJ, Gelder CM, Oxford JS, Stephens HA, Lambkin-Williams R. Moss AJ, et al. Among authors: oxford js. PLoS One. 2013 Aug 9;8(8):e71376. doi: 10.1371/journal.pone.0071376. eCollection 2013. PLoS One. 2013. PMID: 23951151 Free PMC article. Clinical Trial.
Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals.
Bagga B, Woods CW, Veldman TH, Gilbert A, Mann A, Balaratnam G, Lambkin-Williams R, Oxford JS, McClain MT, Wilkinson T, Nicholson BP, Ginsburg GS, Devincenzo JP. Bagga B, et al. Among authors: oxford js. Antivir Ther. 2013;18(6):785-91. doi: 10.3851/IMP2629. Epub 2013 May 28. Antivir Ther. 2013. PMID: 23714753
Clinical, scientific and ethnographic studies of influenza in quarantine.
Oxford JS, Oxford JR. Oxford JS, et al. Expert Rev Vaccines. 2012 Aug;11(8):929-37. doi: 10.1586/erv.12.77. Expert Rev Vaccines. 2012. PMID: 23002974
Effectiveness of H1N1 vaccination in Scotland, UK.
Oxford JS. Oxford JS. Lancet Infect Dis. 2012 Sep;12(9):653-4. doi: 10.1016/S1473-3099(12)70154-8. Epub 2012 Jun 26. Lancet Infect Dis. 2012. PMID: 22738891 No abstract available.
199 results
Jump to page